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The focal adhesion kinase, FAK or pp125 FAK , is a 125 kDa protein tyrosine kinase (PTK), whose name is derived from its subcellular localization (Schaller et al. 1992) . Although originally identified as a putative substrate for pp60 v-src (Kanner et al. 1990) , an oncogenic PTK, FAK has gained its notoriety as an element of a signaling pathway regulated by cell surface receptors called integrins (Schaller & Parsons 1993 . Integrins are heterodimeric, transmembrane proteins that can simultaneously bind to proteins of the extracellular matrix (ECM), e.g. fibronectin, and to components of the actin cytoskeleton, e.g. talin and -actinin (Burridge et al. 1988 , Turner & Burridge 1991 . In addition to their role in cell adhesion to ECM and in anchoring the cytoskeleton, the integrins can transduce extracellular cues into cytoplasmic signals (Damsky & Werb 1992 , Hynes 1992 , Schwartz 1992 , Juliano & Haskill 1993 , which include the tyrosine phosphorylation and enzymatic activation of FAK (Burridge et al. 1992 , Guan & Shalloway 1992 , Hanks et al. 1992 , Kornberg et al. 1992 , Lipfert et al. 1992 .
The integrins may play a fundamental role in a number of biological processes including adhesion to extracellular matrix, intercellular adhesion, the maintenance of cell morphology, cell migration and the regulation of cell growth and differentiation (Hynes 1992) . Through regulation of these basic cellular processes the integrins contribute to the normal development and homeostasis of multicellular organisms, e.g. in establishing tissue organization, blood clotting and in lymphocyte adhesion. Although their function in endocrine cells has not been extensively studied, the integrins play critical roles in the development and normal function of other epithelial tissues. For example, integrin-dependent adhesion to ECM proteins suppresses the expression of a differentiation specific marker in keratinocytes (Adams & Watt 1989) . Conversely, the synthesis of milk proteins in mammary epithelial cells is dependent upon integrins binding to their extracellular ligands (Streuli et al. 1991) . Thus integrins play an important role in regulating differentiation and/or gene expression in these systems. Given these precedents, it is likely that integrin/ECM interactions also profoundly affect some aspect of endocrine cell behavior.
The FAK family of PTKs
FAK is a highly conserved protein, exhibiting 90% amino acid identity between the Xenopus, avian, murine and human homologues (Hanks et al. 1992 , Schaller et al. 1992 , Andre & Becker-Andre 1993 , Choi et al. 1993 , Whitney et al. 1993 , Hens & DeSimone 1995 . FAK contains a central catalytic domain flanked by NH 2 -and C-terminal noncatalytic domains (see Fig. 1A ). Although the function of the NH 2 -terminus of FAK remains to be firmly established, the C-terminal domain is comprised of multiple binding sites for cytoskeletal and signaling proteins and probably functions to facilitate the assembly of multiprotein complexes (see below). The C-terminal 150 residues of FAK contain the focal adhesion targeting (FAT) sequence which is responsible for directing and/or anchoring FAK to cellular focal adhesions (Hildebrand et al. 1993) .
FAK is now the prototypical member of a small family of PTKs comprised of two members, FAK and PYK2/ CAK (Lev et al. 1995 , Sasaki et al. 1995 . FAK and PYK2/CAK exhibit 45% amino acid identity (60% in the catalytic domain) and like FAK, PYK2/CAK contains a central catalytic domain flanked by large NH 2 -and C-terminal noncatalytic domains (see Fig.  1B ). Despite the similarities in amino acid sequence between these two PTKs, PYK2/CAK does not localize to cellular focal adhesions and its tyrosine phosphorylation is not regulated by adhesion to ECM proteins. PYK2/CAK is localized to sites of cell-cell contact (Sasaki et al. 1995) and appears to be regulated by changes in cytoplasmic Ca 2+ (Lev et al. 1995) . PYK2/CAK can induce the tyrosine phosphorylation of the Kv1·2 potassium channel which results in suppression of the passage of current (Lev et al. 1995) . Despite their different subcellular localization, and presumably function, a number of binding sites for SH2 and SH3 domain-containing FAK binding proteins are conserved in PYK2/CAK (Table 1) . Thus the same signaling molecules may be recruited into the signaling pathways regulated by FAK and PYK2/CAK .
Functions of FAK
FAK regulates cell spreading and migration Perhaps the most pressing issue in FAK signaling is the identification of the biological response controlled by FAK. FAK is clearly essential for embryonic development since the homozygous FAK knockout is an embryonic lethal (Ilic et al. 1995) . FAK has been proposed to function in the assembly of cellular focal adhesions and cell spreading on ECM proteins since inhibitors of PTKs inhibit both events (Burridge et al. 1992 et al. 1995) . FAK may also function in cell migration since motogenic stimuli, e.g. hepatocyte growth factor (scatter factor), trigger the phosphorylation of FAK (Matsumoto et al. 1994) . Platelet-derived growth factor (PDGF) also stimulates FAK tyrosine phosphorylation with a dose response that correlates with PDGF-induced chemotaxis rather than PDGF-induced DNA synthesis (Rankin & Rozengurt 1994 , Abedi et al. 1995 . Tyrosine kinase inhibitors block the migration of human umbilical vein endothelial cells (HUVEC) in wound healing, implicating some PTK in endothelial cell migration (Romer et al. 1994 ). This kinase is likely to be FAK since the introduction of a dominant negative mutant of FAK, i.e. the C-terminal domain, also inhibits the migration of HUVECs (A P Gilmore & L H Romer, personal communication). Finally FAK-deficient fibroblasts show retarded motility (Ilic et al. 1995) . These results implicate FAK as a regulatory protein in the basic cellular processes of cell spreading and migration.
FAK: a role in human disease? FAK may play a role in the pathology of human disease. It was originally isolated as a candidate substrate for pp60 src and subsequently shown to be a pp60 src -binding protein (Kanner et al. 1990 , Cobb et al. 1994 . FAK is thus a candidate for a mediator of some of the effects of src transformation in cells in tissue culture. Enzymatically activated pp60 src has recently been found in some human tumors suggesting that the analysis of the pp60 src model may be directly applicable to human cancer (Bolen et al. 1987 , Cartwright et al. 1990 , Takekura et al. 1990 , Fanning et al. 1992 , Ottenhoff-Kalff et al. 1992 , Talamonti et al. 1993 , Cartwright et al. 1994 . Changes in cell surface expression of integrins can modify the tumorigenic and metastatic properties of cells (Albelda 1993 , Juliano & Varner 1993 , which could conceivably be mediated by altered signaling through FAK. Finally FAK expression levels are elevated in some tumors (Weiner et al. 1993 , Owens et al. 1995 . Although these early results are provocative, a true assessment of the value of FAK perturbations as diagnostic or prognostic indicators await more extensive analyses. For these reasons, the investigation of FAK as a potential modulator of some aspects of cancer continues. Indeed as a regulator of basic cellular responses, e.g. migration, FAK may also contribute to the development of other human diseases, e.g. vascular diseases involving the hyperproliferation and migration of vascular smooth muscle cells. 
Mechanism of action of FAK
Tyrosine phosphorylation of FAK FAK was first shown to be linked to integrin signaling when it was identified as a major substrate for tyrosine phosphorylation, concomitantly becoming enzymatically activated, following antibody crosslinking of cell surface integrins or upon integrin-dependent cell adhesion (Burridge et al. 1992 , Guan & Shalloway 1992 , Hanks et al. 1992 , Kornberg et al. 1992 , Lipfert et al. 1992 . Subsequently, many other stimuli have been shown to induce the tyrosine phosphorylation of FAK including extracellular ligands that stimulate G-protein linked receptors, e.g. bombesin (Zachary et al. 1992 , ligands that activate receptor protein tyrosine kinases, e.g. plateletderived growth factor (Rankin & Rozengurt 1994) , and other ligands whose mode of signaling is presently obscure, e.g. hyaluronic acid (Hall et al. 1994) . Thus multiple stimuli that signal through diverse pathways converge to induce the tyrosine phosphorylation of a common substrate, FAK (see Table 2 ). The integrity of the actin cytoskeleton is crucial for signaling to FAK since cytochalasin D treatment abrogates the tyrosine phosphorylation of FAK in response to many of these stimuli (Lipfert et al. 1992 , Rankin & Rozengurt 1994 , Seufferlein & Rozengurt 1994 et al. 1989 , Sekine et al. 1989 , Paterson et al. 1990 . Furthermore, treatment of permeabilized cells with GTP S, which stimulates the activity of GTP binding proteins, induces the tyrosine phosphorylation of FAK and this response is eliminated if the cells are pretreated with C3 toxin (Seckl et al. 1995) . The GTP S-induced tyrosine phosphorylation of FAK can also be blocked with a synthetic peptide identical in sequence to the effector domain of Rho, which should bind to downstream signaling elements and uncouple Rho from its downstream effectors (Seckl et al. 1995) . Table 1 ) , Schlaepfer et al. 1994 , Calalb et al. 1995 . It is intriguing that FAK can be phosphorylated by other PTKs since some of the stimuli that slightly reduces the enzymatic activity of FAK measured in an in vitro PTK assay suggesting that phosphorylation of these residues may play a small role in the regulation of FAK's enzymatic activity , Calalb et al. 1995 . Elimination of all three sites has a more pronounced effect upon kinase activity (Calalb et al. 1995) . Perhaps more importantly, tyrosine phosphorylation of FAK regulates complex formation with signaling proteins that contain SH2 domains. SH2 domains are motifs that mediate protein-protein interactions by specifically binding to tyrosine phosphorylated residues in the context of specific amino acid sequences (Cohen et al. 1995 , Pawson 1995 . Tyrosine phosphorylation at Y 397 of FAK creates a high affinity binding site for the SH2 domain of pp60 src , whereas tyrosine phosphorylation at Y 925 creates a GRB2 SH2 domain binding site (Schlaepfer et al. 1994 ) (see Table 3 ). The association of FAK with GRB2 implicates p21 ras as a downstream component of FAK signaling since GRB2, a small adaptor protein, regulates the activation of p21 ras through an associated guanine nucleotide exchange factor (Cohen et al. 1995 , Pawson 1995 . Complex formation between FAK and pp60 src or GRB2 may serve to recruit these signaling molecules to the vicinity of activated FAK resulting in generation of signals in specific cellular locales. Binding of pp60 src to FAK may also serve to activate pp60 src . Current models of pp60 src regulation envision repression of enzymatic activity by a physical interaction between the tyrosine phosphorylated negative regulatory domain of pp60 src and its own SH2 domain (Cooper & Howell 1993) . Complex formation with FAK might displace the negative regulatory domain from the SH2 domain snapping pp60 src into its active configuration ).
More FAK binding proteins FAK can bind through sequences that partially overlap the FAT sequence to two focal adhesion-associated proteins, talin and paxillin (Turner & Miller 1994 , Chen et al. 1995 , Hildebrand et al. 1995 ) (see Table 3 ). Talin also binds to the cytoplasmic domain of 1 integrins and to another cytoskeletal protein, vinculin, and through these interactions is believed to be instrumental in the anchorage of the actin cytoskeleton to integrins (Burridge et al. 1988 , Turner & Burridge 1991 . Paxillin is also a vinculin-binding protein (Turner et al. 1990 ) and the binding site for both vinculin and FAK is located in the NH 2 -terminal half of the molecule (Turner & Miller 1994) . Upon tyrosine phosphorylation, paxillin can complex with a number of SH2-containing signaling molecules (Birge et al. 1993 , Sabe et al. 1994 , Bergman et al. 1995 . Despite the fact that the FAT sequence of FAK overlaps the binding sites for paxillin and talin, mutational analysis of FAK has revealed that binding to neither protein alone is responsible for tethering FAK in focal adhesions (Chen et al. 1995 , Hildebrand et al. 1995 . It is therefore possible that this region of FAK binds to yet another protein responsible for targeting FAK to focal adhesions.
The C-terminal domain of FAK is relatively proline rich and includes binding sites for two SH3 domaincontaining proteins. SH3 domains mediate proteinprotein interactions by binding to specific proline-rich sequences (Cohen et al. 1995 , Pawson 1995 . The sequence around proline 712 (P 712 ) and P 715 of FAK serves as a binding site for the SH3 domain of p130 cas (Polte & Hanks 1995, A H Bouton, personal communication) and the sequence around P 878 binds to the SH3 domain of a novel GTPase activating protein (GAP) called GRAF (J D Hildebrand and J T Parsons, personal communication) (see Table 3 ). p130
cas has an NH 2 -terminal SH3 domain and a large tyrosine-rich region containing multiple consensus SH2 binding sites (Sakai et al. 1994) . Like paxillin, p130 cas localizes to focal adhesions (Petch et al. 1995) and upon tyrosine phosphorylation binds to a number of signaling molecules (Sakai et al. 1994) . A p130 cas -related protein, HEF1, was isolated as a human cDNA which induced pseudohyphal growth when expressed in yeast (S Law and E Golemis, personal communication). Like p130 cas , HEF1 can bind to FAK through its NH 2 -terminal SH3 domain. Association with FAK may facilitate the tyrosine phosphorylation of p130 cas or tether p130 cas and its associated proteins in a specific cellular location. The Rho-GAP-like protein, GRAF, shares homology with the catalytic domain of GAPs for the Rho family of GTP binding proteins, and has been shown to catalyze the hydrolysis of GTP bound to Cdc42 and Rac to GDP in vitro (J D Hildebrand and J T Parsons, personal communication). GRAF may serve as an effector protein for GTP binding proteins in the vicinity of FAK or may function as a negative regulatory protein that terminates signal transduction by these proteins.
FAK also associates with phosphatidylinositol 3-kinase (PI3K). Following cell adhesion, this interaction correlates with the tyrosine phosphorylation of FAK and may be mediated in part by the SH2 domain of the p85 subunit of PI3K (Chen & Guan 1994a) . Conversely, following PDGF stimulation, complex formation between FAK and PI3K does not correlate with FAK phosphorylation (Chen & Guan 1994b) . Furthermore, the SH3 domain of p85 can bind directly to FAK in vitro and a synthetic peptide mimicking residues 706-711 of FAK can bind to the p85 SH3 domain, stimulating PI3K activity twofold (Guinebault et al. 1995) . In thrombin-stimulated platelets the translocation of PI3K to the cytoskeleton correlates with its association with FAK (Guinebault et al. 1995) . Thus this interaction may serve to target PI3K to a discrete region of the cell and regulate its activity.
FAK may also be an integrin-binding protein since the NH 2 -terminal domain of FAK can associate with synthetic peptides mimicking the cytoplasmic domain of the 1 integrin subunit . This interaction plays no role in the association of FAK with focal adhesions. This observed interaction suggests the intriguing hypothesis that FAK may be regulated through binding to the integrin, a hypothesis that remains to be tested. and all three proteins become coordinately phosphorylated on tyrosine in response to multiple stimuli (Burridge et al. 1992 , Guan & Shalloway 1992 , Kornberg et al. 1992 , Lipfert et al. 1992 , Zachary et al. 1992 , Rankin & Rozengurt 1994 , Seufferlein & Rozengurt 1994 , Nojima et al. 1995 , Petch et al. 1995 ) (see Table 3 ). Experimentally, the tyrosine phosphorylation of paxillin can be induced in a pp125 FAK -dependent manner . The induction of paxillin phosphorylation depends upon the integrity of the pp60 src binding site within pp125
Substrates of FAK
FAK , suggesting that FAK might regulate paxillin phosphorylation by directing the activity of pp60 src toward this substrate . Paxillin is a substrate for tyrosine phosphorylation by both pp125 FAK and pp60 src in vitro and becomes phosphorylated at tyrosine residues 31 and 118 both in vitro and in vivo (Bellis et al. 1995 . Tyrosine phosphorylation of paxillin creates binding sites for the SH2 domain containing proteins Crk and Csk (Birge et al. 1993 , Sabe et al. 1994 . Crk, like GRB2, is an adaptor protein that serves to dock other signaling molecules, e.g. the p21 ras guanine nucleotide exchange factor Sos (Matsuda et al. 1994) , to tyrosine phosphorylated proteins, e.g. paxillin.
Csk is a PTK that can phosphorylate a negative regulatory site within pp60 src and repress its enzymatic activity (Nada et al. 1991) . Tyrosine phosphorylation of p130 cas also creates binding sites for SH2 domain-containing signaling molecules including Crk and pp60 src (Sakai et al. 1994) . Thus by regulating the phosphotyrosine content of paxillin and p130 cas , FAK could regulate the assembly of signaling complexes at discrete sites within the cell.
Tensin is an SH2 domain-containing, actin binding, focal adhesion-associated, cytoskeletal protein (Davis et al. 1991 , Lo et al. 1994 . The observations that tensin colocalizes with pp125 FAK and becomes tyrosine phosphorylated upon cell adhesion suggests that tensin is a FAK substrate (Bockholt & Burridge 1993) . Like paxillin, the tyrosine phosphorylation of tensin can be induced experimentally in a FAK-dependent manner (M D Schaller, unpublished observations), although the consequences of tyrosine phosphorylation of tensin are unknown. PI3K is also a candidate substrate for FAK since the two molecules physically associate and the 85 kDa subunit of PI3K becomes tyrosine phosphorylated in response to cell adhesion (Chen & Guan 1994a).
The evidence described above identifies these proteins as candidate substrates of FAK. However, a number of these proteins exhibit tyrosine phosphorylation in FAKdeficient fibroblasts (Ilic et al. 1995) . This observation may indicate the existence of multiple mechanisms of phosphorylation of these substrates, only one of which is FAK dependent.
Future prospects
The intense scrutiny under which FAK has fallen has led to the rapid identification of its associated proteins and potential substrates. Emerging evidence has implicated FAK as a regulator of cell morphology and migration. Numerous laboratories are striving to elucidate the biochemical pathways that (i) regulate FAK activity and (ii) are utilized by FAK to regulate these biological functions. The successful completion of these studies will provide valuable insight into the mechanisms of regulation of cellular processes such as migration. Once the key elements within this signaling pathway(s) are identified and the way in which these proteins physically and functionally interact are discovered, rational approaches to specifically disrupt certain of these interactions and abrogate part of the downstream signal will be devised. These tools will be applied to explore FAK regulated signaling further and may serve as the prototypes in the design of novel strategies to control cellular behavior in the treatment of human disease.
